138 related articles for article (PubMed ID: 18982511)
21. Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors.
Meyer MW; Zachariae C; Bendtzen K; Skov L
Acta Derm Venereol; 2012 Jul; 92(4):362-4. PubMed ID: 22864558
[No Abstract] [Full Text] [Related]
22. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
Van Lümig PP; Lecluse LL; Driessen RJ; Spuls PI; Boezeman JB; van de Kerkhof PC; De Jong EM
Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
[TBL] [Abstract][Full Text] [Related]
23. [Introduction to biological drugs].
Fernández-Cruz E; Alecsandru D; Rodríguez-Sainz C
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():2-6. PubMed ID: 19080985
[TBL] [Abstract][Full Text] [Related]
24. Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
[No Abstract] [Full Text] [Related]
25. Misunderstandings.
Feldman SR
J Dermatolog Treat; 2007; 18(1):4. PubMed ID: 17365258
[No Abstract] [Full Text] [Related]
26. A global approach to psoriatic patients through PASI score and Skindex-29.
Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
[TBL] [Abstract][Full Text] [Related]
27. [Psoriasis updates].
Boulinguez S
Ann Dermatol Venereol; 2010 May; 137(5 Suppl 1):1-4. PubMed ID: 20510173
[No Abstract] [Full Text] [Related]
28. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
Girolomoni G; Abeni D
Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
[No Abstract] [Full Text] [Related]
29. Switching biological agents for psoriasis in secondary care: a single-centre, retrospective, open-label study.
Woo WA; Waite A; Rustin MH; McBride SR
Br J Dermatol; 2014 Apr; 170(4):989-90. PubMed ID: 24298875
[No Abstract] [Full Text] [Related]
30. [Biological therapeutic agents and patient autonomy in dermatologic therapy. The Danish Society of Dermatology].
Bygum A; Jemec GB
Ugeskr Laeger; 2004 Mar; 166(12):1105. PubMed ID: 15067764
[No Abstract] [Full Text] [Related]
31. Erythroderma in the era of biological therapies.
Zattra E; Belloni Fortina A; Peserico A; Alaibac M
Eur J Dermatol; 2012; 22(2):167-71. PubMed ID: 22321651
[TBL] [Abstract][Full Text] [Related]
32. [What's new in dermatological treatments?].
Martin L
Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S165-76. PubMed ID: 21193120
[TBL] [Abstract][Full Text] [Related]
33. Treatment of necrobiosis lipoidica with etanercept and adalimumab.
Zhang KS; Quan LT; Hsu S
Dermatol Online J; 2009 Dec; 15(12):12. PubMed ID: 20040262
[No Abstract] [Full Text] [Related]
34. Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders.
Hession MT; Gottlieb AB
J Dermatolog Treat; 2011 Apr; 22(2):90-101. PubMed ID: 20673155
[TBL] [Abstract][Full Text] [Related]
35. Viewpoint on handling anti-TNF failure in psoriasis.
Bracke S; Lambert J
Arch Dermatol Res; 2013 Dec; 305(10):945-50. PubMed ID: 24096701
[TBL] [Abstract][Full Text] [Related]
36. [TNF-alpha inhibitors and demyelinating disease].
Böttiger Y
Lakartidningen; 2007 Nov 7-13; 104(45):3384. PubMed ID: 18062640
[No Abstract] [Full Text] [Related]
37. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
38. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
Nijsten T; Spuls PI
Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
[No Abstract] [Full Text] [Related]
39. Anti-TNF agents for the treatment of psoriasis.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380
[TBL] [Abstract][Full Text] [Related]
40. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Gordon KB; Ruderman EM
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
